Bunge Global (BG) Barclays 19th Annual Global Consumer Conference summary
Event summary combining transcript, slides, and related documents.
Barclays 19th Annual Global Consumer Conference summary
9 Sep, 2026Strategic positioning and integration
The Viterra merger expanded geographic and product diversification, enhancing risk management and customer reach across all key producing regions.
Integration planning benefited from a lengthy regulatory process, enabling smooth operational alignment and commercial synergy realization.
The combined platform now optimizes origination, processing, and distribution, especially with the addition of Argentina's Renova facility.
Softseed and oilseed capabilities are now more balanced, with improved origination and processing chains for canola, rapeseed, and sunflower.
The organization is unified post-merger, focusing on leveraging network synergies and strategic customer relationships.
Financial outlook and capital allocation
Adjusted EPS guidance was raised due to strong first-half performance, resilient demand for soybean oil and meal, and improved global results.
Cost synergies from the Viterra deal are ahead of schedule, with $190 million expected in 2026 and a run rate surpassing $200 million by year-end.
Capital structure improvements include debt refinancing at record-low spreads and completion of a $2 billion share buyback.
By 2030, the plan is to allocate $700 million each to dividends and share buybacks, ramping up as CapEx declines post-2027.
CapEx is expected to decrease from $1.5–$1.7 billion in 2024 to $1.1 billion by late 2027, freeing cash for shareholder returns.
Market dynamics and operational strategy
The company benefits from structural changes in global oilseed and softseed markets, leveraging its integrated footprint to adapt to shifting trade flows.
Direct sourcing from farmers is targeted to increase from just over half to two-thirds, improving quality control and financial flexibility.
The Amsterdam tropical oils refinery project, consolidating two plants, aims to boost efficiency and customer offerings by 2027.
Specialty protein and oil segments are positioned for growth, with new facilities and cross-selling opportunities supporting market share gains.
The organization is prepared to flex its network, pursue bolt-on acquisitions, and debottleneck assets for high-return investments.
Latest events from Bunge Global
- Q2 2026 net income and adjusted EPS nearly doubled, outlook raised, and $2B buyback completed.BG
Q2 2026 - Expanded global network and strong demand drive above-baseline margins and strategic flexibility.BG
21st Annual Global Farm to Market Conference - Raised full-year adjusted EPS guidance to $9.00–$9.50 after strong Q1 processing results.BG
Q1 2026 - Virtual annual meeting to vote on financials, dividends, board elections, and compensation.BG
Proxy filing - Adjusted EPS was $7.57, with strong segment EBIT and Viterra integration driving 2026 guidance of $7.50–$8.00.BG
Q4 2025 - Q3 adjusted EPS was $2.27, with Viterra integration fueling record sales and segment EBIT.BG
Q3 2025 - Q2 GAAP EPS rose to $2.61; Viterra merger and corn milling sale completed; $7.75 EPS outlook held.BG
Q2 2025 - Q3 earnings and margins declined, but full-year adjusted EPS guidance raised to at least $9.25.BG
Q3 2024 - 2025 adjusted EPS guided to $7.75 as strategic deals close amid a challenging market.BG
Q4 2024